sr141716 has been researched along with Injuries, Spinal Cord in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, M; Baty, DE; Ganea, D; Gaughan, J; Heller, JE; Jallo, JI; Li, H; Loftus, CM; Tuma, RF; Zhang, M | 1 |
| Clarke, RW; Harris, J; Jenkins, S; Witton, SK | 1 |
2 other study(ies) available for sr141716 and Injuries, Spinal Cord
| Article | Year |
|---|---|
The combination of selective inhibition of the cannabinoid CB1 receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of spinal cord injury.
Topics: Animals; Autonomic Nervous System; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred C57BL; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Cord Injuries; Urinary Bladder | 2009 |
Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit.
Topics: Animals; Decerebrate State; Dose-Response Relationship, Drug; Dronabinol; Female; Fentanyl; Male; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rabbits; Receptors, Cannabinoid; Receptors, Drug; Reflex; Rimonabant; Spinal Cord; Spinal Cord Injuries | 2001 |